Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by LordoftheMarketon Feb 05, 2018 2:24pm
89 Views
Post# 27505485

RE:RE:ISOL is currently doing higher Revenues than GW Pharma

RE:RE:ISOL is currently doing higher Revenues than GW Pharma
Canopy Growth (TSX: WEED) 09/30/17 C$17.57m 107%  02/14/18
MedReleaf (TSX: LEAF) 09/30/17 C$9.82m -9%  02/13/18
Aphria (TSX: APH) 11/30/17 C$8.50m 63% ~04/16/18
Aurora Cannabis (TSX: ACB) 09/30/17 C$8.25m 169%  ~02/14/18
CannTrust (CSE: TRST) 09/30/17 C$6.14m 680% ~04/30/18
Isodiol International (CSE: ISOL) 09/30/17 C$5.06m n/a  ~3/01/18





https://www.newcannabisventures.com/cannabis-company-revenue-ranking/
Bullboard Posts